Medicine and Dentistry
Fecal Microbiota Transplantation
100%
Infection
61%
Inflammatory Bowel Disease
46%
Crohn's Disease
30%
Patient with Inflammatory Bowel Disease
22%
Tumor Necrosis Factor
20%
Disease
16%
Clostridium Difficile Infection
16%
Prospective Cohort Study
15%
Placebo
15%
Thiamine
15%
Ileostomy
15%
Feces
15%
Cohort Analysis
14%
Ulcerative Colitis
13%
Combination Therapy
12%
Intestinal Failure
11%
Biological Therapy
11%
Drug Megadose
11%
Vancomycin
10%
Disease Activity
10%
Bioelectrical Impedance Analysis
10%
Biological Marker
10%
Quality of Life
9%
Fistula
9%
C Reactive Protein
8%
Maintenance Therapy
8%
Gut Microbiota
8%
T Cell
8%
Systematic Review
8%
Antibiotics
8%
Infliximab
8%
Health Care Cost
7%
Autonomic Dysfunction
7%
Cross Sectional Study
7%
Cohort Study
7%
Cost-Effectiveness Analysis
7%
Birth Weight
6%
Home Parenteral Nutrition
6%
Biological Product
5%
Randomized Clinical Trial
5%
Mercaptopurine
5%
Outpatient
5%
Faecal Calprotectin
5%
Adverse Event
5%
Colectomy
5%
Frailty
5%
Disease Severity
5%
Odds Ratio
5%
Blood Donor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Feces microflora
57%
Infection
49%
Inflammatory Bowel Disease
40%
Crohn's Disease
31%
Tumor Necrosis Factor
20%
Combination Therapy
16%
Ulcerative Colitis
16%
Cohort Study
14%
Disease
12%
Disease Activity
11%
Infliximab
10%
Vancomycin
10%
Biological Marker
8%
Clostridium Difficile Infection
7%
Adalimumab
7%
Intestine Flora
7%
Placebo
7%
Thiamine
7%
Prospective Cohort Study
7%
Remission
7%
Inflammation
7%
Antibiotic Agent
7%
Mercaptopurine
6%
Prevalence
6%
Vitamin D
6%
Randomized Controlled Trial
6%
Disease Course
5%
Fidaxomicin
5%
Monotherapy
5%
Methotrexate
5%
Immunology and Microbiology
Feces microflora
52%
Crohn's Disease
51%
Inflammatory Bowel Disease
32%
Tumor Necrosis Factor
18%
T Cell
16%
Infliximab
14%
Adalimumab
14%
Intestine Flora
13%
C-Reactive Protein
10%
Dendritic Cell
9%
Regulatory T Cell
9%
Feces
8%
Ulcerative Colitis
8%
Secretion (Process)
7%
Oligomerization
7%
Granulocyte Macrophage Colony-Stimulating Factor
7%
Toll-Like Receptor
7%
Inflammatory Disorder
7%
CD163
7%
Normal Human
7%
Cytokine
6%
Microflora
6%
Interleukin 10
5%
Inflammatory Arthritis
5%
Probiotic
5%
Monospecific Antibody
5%
